Amyloidosis and Medical Cannabis
When the protein called amyloid is formed in the body, it can form in organs and bones. The heart, kidneys, spleen, nervous system or digestive tract will stop working. It does this slowly and sometimes people die because of it. Research has shown that people with amyloidosis can benefit from medical cannabis. There is no known cure, but the symptoms are treatable.
Amyloidosis: Understanding Its Effects
Amyloidosis doesn’t attack the same organs for everyone. Some people’s amyloidosis affects different parts of their body. There are three types of amyloidosis. Primary amyloidosis does not have a cause. Secondary amyloidosis is caused by cancer. Familial amyloidosis is passed down in families. There are many types of amyloidosis, but the most common type is Alzhemier’s disease.
The symptoms of this disease are different for each person. You need to know which type of amyloidosis you have. Heart-related symptoms are shortness of breath and an irregular heartbeat. Other indicators include swelling in the legs, stomach, arms, and lungs. Nerves may show as numbness or carpal tunnel syndrome. Gastrointestinal problems could be a large tongue or unexplained weight loss.
Treating Amyloidosis is difficult. It includes high-dose chemotherapy, steroids, and liver and kidney transplants.
Potential Benefits of Medical Cannabis for Amyloidosis
The Amyloidosis Foundation reports that the U.S. Office of Rare Diseases brands the condition as a rare one, which affects less than 200,000 people in America. The foundation says that the most significant setback is that some people do not get diagnosed quickly. This is why reports of medical cannabis calming the condition are hopeful.
CBD is a chemical that prevents amyloid from building up. THC can help prevent symptoms of nausea, anxiety, and depression. It has been suggested that CBD can be used to treat amyloidosis. Its anti-inflammatory properties make it a potential treatment for this disease. Additionally, it can also be beneficial for conditions such as a swollen tongue, swollen body parts and organs, and even enlarged tumors.
There are different types of medical cannabis that can be helpful to people who suffer from different types of Amyloidosis. The indica-dominant strains are good when it comes to anxiety, pain, and lack of appetite. The sativa-dominant strains help to alleviate fatigue and nausea as well.
Researchers theorize that THC has beneficial antioxidant properties, and it makes the immune system weaker. That’s good for people who have amyloidosis. In 2004, a study was done on the role of cannabinoids in Alzheimer’s disease. The study suggested that when these cannabinoids are used to treat amyloidosis, they also work to reduce dementia-related disorders. The researchers said that drugs that affect the molecule CB1 and CB2, as well as drugs that affect the enzyme FAAH, may help prevent inflammation in the brain which can lead to Aβ deposits. Further studies will help us know more about this idea. This new idea will help us find out more about cannabinoids and Alzheimer’s Disease.
A study published in the Journal of Alzheimer’s Disease in 2016 suggested that cannabinoid receptor two might be related to the production of amyloid protein in mice. This suggests that cannabis-based treatment could be the answer to dementia. While there are no definitive discoveries related to medical cannabis and amyloidosis to date, preliminary research suggests that both THC and CBD will continue to be at the forefront of possible therapies as long as successful trials continue.